Dyslipidemia Therapeutics Market is expected to be valued at US $ 53.2 Billion by the end of 2033: Fact.MR Study Rockville, June 05, 2023 (GLOBE NEWSWIRE) -- The recent research analysis by Fact.MR on the global market global dyslipidemia therapeutics provides a thorough overview of the industry’s product,...